Bifidumbacterin, vials, 5 doses, 10pcs – Ecopolis

Composition

One dose of the drug contains at least 107 live bifidobacteria.

Auxiliary substance:

Lactulose – 2%, components of the drying medium: sucrose, gelatin, skimmed milk (obrat).

Indications

For diseases of the gastrointestinal tract:

• for the treatment of prolonged intestinal dysfunction is not established etiology;
• in acute intestinal infections (in complex treatment of acute dysentery, salmonellosis, echrishiosis, viral diarrhea, etc. ), prolonged intestinal dysfunction caused by staphylococci, as well as for the treatment of patients after acute intestinal infections in the ongoing dysfunction of the intestine;
• in the complex treatment of children (including newborns, premature), patients with pneumonia, sepsis and other purulent-infectious diseases, for the prevention or relief they have disorders of bowel function and prevent the development of ulcerative-necrotic enterocolitis;
• for the treatment and prevention of dysbacteriosis in children with severe pre-morbid condition, born prematurely or with signs of prematurity receiving antibiotics in the early neonatal period; children whose mothers suffered from toxemia, extragenital diseases, had a long anhydrous period or other pathology; the children of mothers who had lactose, cracked nipples and renewable breast-feeding after recovery from mastitis; impaired children with anemia, malnutrition, rickets, diathesis and other manifestations of Allergy; when the disease whooping cough, especially if they have any disorders of bowel function;
• in the early translation children on artificial feeding or feeding donor milk;
• for the treatment of acute and chronic inflammatory diseases of the large and small intestines (colitis, enterocolitis) in older children and adults, occurring against the background of violations of the microflora with a deficiency or absence of bifidoflora;
• intestinal dysfunction as a result of intestinal dysbiosis, which arose as a consequence of prolonged antibiotic, hormonal, radiation and other therapies, in stressful situations and stay in extreme conditions and prevent dysbiosis these individuals.

In obstetric and gynecological practice:

• to prevent mastitis for the local treatment of breast feeding mothers “risk” (women with flat nipples sucked, while reducing its erection, the presence of cracks) in advanced epidemiological situation in hospitals;
• in violation of the purity of the vaginal secretions to the III – IV degree of pregnant women “risk”;
• in bacterial colpitis caused by Staphylococcus and E. coli (in monoflora or associations), as well as senile obesity hormonal nature.

Use during pregnancy and lactation

Bifidobacteria are representatives of the normal human microflora, so preparations made on their basis can be used during pregnancy and lactation.

Interaction

Clinically significant interaction of the drug with other drugs has not been established. Bifidumbacterin can be used simultaneously with antibacterial, antiviral and immunomodulatory therapy. The effect is enhanced by vitamins (especially Group B), reduced by antibiotics. Corrective therapy with bifidumbacterin can be prescribed after a course of treatment with specific bacteriophages designed to eliminate opportunistic bacteria.

How to take, course of use and dosage

of Bifidumbacterin for intestinal diseases is used orally, and in obstetric and gynecological practice: locally (intravaginally).

1. Treatment and prevention of gastrointestinal diseases:

Dissolve the contents of the bottle with boiled water at room temperature at the rate of 5 ml (teaspoon) of water per 1 dose of the drug.

Dissolution is carried out as follows: pour the required amount of water into a glass (in accordance with the number of doses indicated on the bottle); open the bottle, removing the cap and stopper; transfer a small amount of water from the glass to the bottle; after dissolution (the drug dissolves for no more than 5 minutes with the formation of an opaque homogeneous suspension), transfer the contents of the bottle to the same glass and mix. One teaspoon of the drug dissolved in this way is 1 dose. The dissolved drug is not subject to storage.

The required number of doses (respectively, teaspoons) should be taken 20-30 minutes before meals or 1-1.5 hours after meals. children can be given the drug immediately before feeding.

For intestinal diseases: children of the first half of life are prescribed 5 doses per reception 2 times a day, children of the second half and older-5 doses 3 times a day.

It is advisable for newborns of the “risk” group to start using the drug in the maternity ward from the first day of life until discharge,2.5 doses per reception 2 times a day.

Children with sepsis, pneumonia and other purulent-infectious diseases are prescribed 5 doses 3 times a day in combination with generally accepted methods of treating the underlying disease. If this group of children develops disorders of the gastrointestinal tract and the threat of ulcerative-necrotic enterocolitis, the dosage of bifidumbacterin is increased to 20 doses per day.

For acute and chronic inflammatory diseases of the small and large intestines, children over 3 years of age and adults are recommended to take 5 doses 2-3 times a day. In severe cases, the dose may be doubled.

The duration of treatment with bifidumbacterin is determined by the severity of clinical manifestations, the age of the patient and is 2-4 weeks, and in some cases-up to 3 months.

For preventive purposes, the drug is prescribed 5 doses 1-2 times a day for 1-2 weeks.

2. In obstetric and gynecological practice:

To treat the area of the nipple and areola of puerperas, the contents of one bottle (5 doses) are dissolved in a small amount of cooled boiled water, soaked in a solution of 2 sterile swabs, which are applied to the nipple and areola for 20-30 minutes before each feeding for 5 days. A tampon soaked in the preparation is left on the surface of the breast until feeding begins.

In case of inflammatory diseases of the female genitals and prenatal preparation of pregnant women of the “risk” group, bifidumbacterin is prescribed 5-10 doses 1 time a day for 5-8 days under the control of restoring the purity of vaginal secretions to I-II degree and the disappearance of clinical symptoms of the disease.

For intravaginal use, bifidumbacterin is also dissolved in the above method. The resulting suspension of the drug is soaked in a sterile swab, which, without squeezing, is introduced intravaginally and left for 2-3 hours.

If necessary, the course of treatment with bifidumbacterin can be repeated.

Description

Crystalline or porous mass with possible stratification of biomass in the upper part, beige or whitish-gray in color, with a specific smell.

Special instructions

The drug does not affect the performance of activities that require special attention and quick reactions (driving vehicles, machinery, etc. ).

Form of production

5,10 doses in a bottle; 10 vials in a pack with instructions for use.

Storage conditions

The drug is stored in accordance with SP 3.3.2.1248-03, at a temperature not exceeding 10° C, out of the reach of children.

Transportation conditions.

Transportation is carried out in accordance with SP 3.3.2.1248-03, at a temperature not exceeding 10° C.

Not suitable for use:

• after the expiration date, or stored with non-compliance with the regulated conditions;
• the integrity of the package is broken (cracked vials);
• without labeling on the bottle;
• with altered physical properties (discoloration, wrinkling of biomass), or in the presence of foreign inclusions.

Shelf

life is 2 years.

Active ingredient

of Bifidobacterium bifidum

Dosage form

powder for oral use

Purpose

For adults, Children over 3 years old

Indications

Diarrhea, After a course of antibiotic therapy, Colitis, Dysbiosis, Irritable Bowel syndrome, Intestinal infections